Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Oxidized ApoC1 on MALDI-TOF and glycated-ApoA1 band on gradient gel as potential diagnostic tools for atherosclerotic vascular disease.

Chang CT, Liao HY, Chang CM, Chen CY, Chen CH, Yang CY, Tsai FJ, Chen CJ.

Clin Chim Acta. 2013 May;420:69-75. doi: 10.1016/j.cca.2012.10.017. Epub 2012 Oct 15.

PMID:
23078847
2.

Analysis of protein glycation products by matrix-assisted laser desorption ionization time-of-flight mass spectrometry.

Kislinger T, Humeny A, Pischetsrieder M.

Curr Med Chem. 2004 Aug;11(16):2185-93. Review.

PMID:
15279557
3.

Differential capture of serum proteins for expression profiling and biomarker discovery in pre- and posttreatment head and neck cancer samples.

Freed GL, Cazares LH, Fichandler CE, Fuller TW, Sawyer CA, Stack BC Jr, Schraff S, Semmes OJ, Wadsworth JT, Drake RR.

Laryngoscope. 2008 Jan;118(1):61-8.

PMID:
18043497
6.

Finding diabetic nephropathy biomarkers in the plasma peptidome by high-throughput magnetic bead processing and MALDI-TOF-MS analysis.

Hansen HG, Overgaard J, Lajer M, Hubalek F, Højrup P, Pedersen L, Tarnow L, Rossing P, Pociot F, McGuire JN.

Proteomics Clin Appl. 2010 Sep;4(8-9):697-705. doi: 10.1002/prca.200900169.

PMID:
21137087
7.

Proteomics and cardiovascular disease: an update.

Balestrieri ML, Giovane A, Mancini FP, Napoli C.

Curr Med Chem. 2008;15(6):555-72. Review.

PMID:
18336270
8.

Diagnosis of albuminuria by tryptic digestion and matrix-assisted laser desorption ionization/time-of-flight mass spectrometry.

Cho YT, Chen CW, Chen MP, Hu JL, Su H, Shiea J, Wu WJ, Wu DC.

Clin Chim Acta. 2013 May;420:76-81. doi: 10.1016/j.cca.2012.12.016. Epub 2012 Dec 22.

PMID:
23266772
9.
12.

Matrix-assisted laser desorption ionization/time-of-flight mass spectrometry for clinical diagnosis.

Cho YT, Su H, Huang TL, Chen HC, Wu WJ, Wu PC, Wu DC, Shiea J.

Clin Chim Acta. 2013 Jan 16;415:266-75. doi: 10.1016/j.cca.2012.10.032. Epub 2012 Oct 23. Review.

PMID:
23089072
13.

Shotgun nanoLC-MS/MS proteogenomics to document MALDI-TOF biomarkers for screening new members of the Ruegeria genus.

Christie-Oleza JA, Piña-Villalonga JM, Guerin P, Miotello G, Bosch R, Nogales B, Armengaud J.

Environ Microbiol. 2013 Jan;15(1):133-47. doi: 10.1111/j.1462-2920.2012.02812.x. Epub 2012 Jun 19.

PMID:
22712501
14.

Peptide mass fingerprinting: protein identification using MALDI-TOF mass spectrometry.

Webster J, Oxley D.

Methods Mol Biol. 2005;310:227-40.

PMID:
16350956
16.

Diabetes mellitus, hyperhomocystinemia and atherosclerotic vascular disease in Taiwanese chronic hemodialysis patients: a retrospective study.

Lee CH, Chang HW, Wang IK, Lin CL, Chen TC, Wang PH, Chang HY, Chen JB, Hsu KT, Chuang FR.

Ren Fail. 2004 May;26(3):317-23.

PMID:
15354983
17.

A new strategy for faster urinary biomarkers identification by Nano-LC-MALDI-TOF/TOF mass spectrometry.

Benkali K, Marquet P, Rérolle J, Le Meur Y, Gastinel L.

BMC Genomics. 2008 Nov 14;9:541. doi: 10.1186/1471-2164-9-541.

18.
19.

Serum apolipoproteins C-I and C-III are reduced in stomach cancer patients: results from MALDI-based peptidome and immuno-based clinical assays.

Cohen M, Yossef R, Erez T, Kugel A, Welt M, Karpasas MM, Bones J, Rudd PM, Taieb J, Boissin H, Harats D, Noy K, Tekoah Y, Lichtenstein RG, Rubin E, Porgador A.

PLoS One. 2011 Jan 18;6(1):e14540. doi: 10.1371/journal.pone.0014540.

20.

Elucidation of potential bortezomib response markers in mutliple myeloma patients.

Hsieh FY, Tengstrand E, Pekol TM, Guerciolini R, Miwa G.

J Pharm Biomed Anal. 2009 Jan 15;49(1):115-22. doi: 10.1016/j.jpba.2008.09.053. Epub 2008 Oct 17.

PMID:
19062221

Supplemental Content

Support Center